20.11.2024 15:06:06
|
Insulet Says Omnipod 5 AID System Now Compatible With Abbott's FreeStyle Libre 2 Plus CGM Sensor
(RTTNews) - Insulet Corp. (PODD), a provider of tubeless insulin pump technology, announced Wednesday that the Omnipod 5 Automated Insulin Delivery (AID) System is now compatible with Abbott Laboratories' (ABT) FreeStyle Libre 2 Plus continuous glucose monitoring (CGM) sensor in the U.S.
This makes Omnipod 5 the most connected tubeless AID system in the U.S. As the number one prescribed and number one favorite pump in the U.S., the waterproof, discreet, and wearable Omnipod 5 is the first tubeless AID system that communicates with a CGM, proactively correcting for highs and helping to protect against lows, day and night.
The Omnipod 5 System simplifies diabetes management and has shown to improve results by eliminating the need for multiple daily injections (MDI) therapy and automatically adjusting insulin delivery every five minutes using its advanced SmartAdjust technology.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Insulet Corp Shsmehr Nachrichten
06.11.24 |
Ausblick: Insulet stellt Ergebnisse des abgelaufenen Quartals vor (finanzen.net) | |
23.10.24 |
Erste Schätzungen: Insulet stellt Quartalsergebnis zum abgelaufenen Jahresviertel vor (finanzen.net) | |
07.08.24 |
Ausblick: Insulet zieht Bilanz zum jüngsten Jahresviertel (finanzen.net) | |
24.07.24 |
Erste Schätzungen: Insulet vermeldet Zahlen zum jüngsten Quartal (finanzen.net) |